Abstract:Synergistic chemo-photothermal therapy is considered to be an effective approach for the treatment of melanoma. Polydopamine (PDA) is extensively used in photothermal therapy and drug delivery, but its instability limits its application in tumor therapy. Here, we found that bovine serum albumin (BSA) could be used to prepare stable and well-dispersible PDA nanoparticles (PDA-BSA). The PDA-BSA had a particle size of approximately 120 nm , while it could efficiently encapsulate and release doxorubicin (DOX) in sustained manner upon exposure to the near-infrared light and acidic conditions. The combined application of PDA-BSA/DOX and irradiation showed a strong anti-tumor effects both in vitro and in vivo . Our study suggests that albumin can effectively stabilize PDA for the preparation of drug-loaded nanoparticles with promising synergistic chemo-phototherapeutic effects. Graphical abstract Download : Download high-res image (218KB) Download : Download full-size image Understanding the supramolecular structures and the host and guest interactions of supramolecular systems is crucial to corroborate the biological findings. In this sense, combining experimental and theoretical approaches has allowed to comprehend the interactions between cyclodextrins (CDs) and guest molecules. Herein, biperiden hydrochloride (BPR) was successfully included into the β -cyclodextrin (β CD) using freeze-drying method. The drug solubility increased in presence of β CD and the thermodynamic parameters for the inclusion process determined by isothermal titration calorimetry (ITC). ITC indicated that the β CD supramolecular system formed a 1:1 inclusion complex. The 2D nuclear magnetic resonance (NMR) results for the β CD:BPR suggested an equilibrium between two different supramolecular complexes in solution, since cross peak correlations with to different moieties was observed. The ITC and NMR findings were corroborated by the theoretical calculations. Moreover, the inclusion complexes' cytotoxicity was tested against lung adenocarcinoma cells, demonstrating that β CD:BPR supramolecular system is promising for further investigation, while free BPR demonstrated to be a non-cytotoxic agent against A549 human cells. The recurrent development of resistance to antimicrobial agents threatens the ability for successful treatment of infectious diseases. Hydrophobic antibiotics such as rifampicin (Rif) are particularly affected due to poor bioavailability. On the other hand, proteins play important roles in drug delivery and release. Further, the combination of antimicrobials with therapeutic proteins and their encapsulation in liposomes seems a promising approach for improvement of antimicrobial efficacy. This study aimed to encapsulate Rif simultaneously with a large protein, Human Serum Albumin (HSA) in liposomes made from an inexpensive crude soy lecithin (CSL). Dual liposomes (Rif-HSA-lip) were prepared using a reverse phase evaporation method. The effect of lipid composition and HSA concentration on Rif loading was also investigated. Physicochemical properties, stability of Rif-HSA-lip and Rif release profiles were evaluated. A good encapsulation efficiency was observed (59% for Rif), despite the presence of bulky HSA. This paves the way for encapsulation strategies of other "biologics". The in vitro release profile for Rif from the Rif-HSA-lip was improved and the freeze-dried formulation exhibited good shelf stability over liposomes with no HSA. The presence of HSA in the liposomal membrane is encouraging for potential targeted delivery studies. This study represents an illustrative example of co-loading of antibiotics and proteins into liposomes, which could lead to the development of novel therapeutic tools for tackling antimicrobial resistance. Owing to their specialized characteristic features, nanomaterials have been dynamically employed in various fields including the medical and health sciences. However, unwanted biological interactions of nanomaterials with biomolecules, cells, tissues, organs, or body systems is critically important and not fully understood, yet. Therefore, the aim of the present review is to critically analyse the available evidence and comprehend the journey of nanomaterials in the body after their exposure through different routes (i.e., oral, inhalation, percutaneous or intravenous). Analysis of the literature revealed that upon interaction with biological tissues, nanomaterials induce oxidative stress via generation of super- -Abstract Truncated-

Characterization of polymeric nanoparticles for intravenous delivery: Focus on stability

A comprehensive investigation of the interactions of human serum albumin with polymeric and hybrid nanoparticles

Nanoparticle Tracking Analysis of Polymer Nanoparticles in Blood Plasma

Investigation of nanoparticle dispersibility and stability based on TiO2 analysis by SMLS, DLS, and SEM

Investigating the Effect of Surface Hydrophilicity on the Destiny of PLGA-Poloxamer Nanoparticles in an In Vivo Animal Model

In Vivo Stability of Protein Coatings on Poly Lactic Co Glycolic Nanoparticles

Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics

The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats

Pharmaceutical Considerations and Metabolic Fate of Parenteral Lipid Nanoparticle Dosage Forms

Using Orthogonal Analytical Approaches to Profile Lipid Nanoparticle Physicochemical Attributes

Insight into the Preformed Albumin Corona on in Vitro and in Vivo Performances of Albumin-Selective Nanoparticles

Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation

Intestinal distribution of anionic, cationic, and neutral polymer-stabilized nanocarriers measured with a lanthanide (europium) tracer assay

Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose

Human Serum Albumin in the presence of Small Platinum Nanoparticles

From Physicochemical to Preclinical Evaluation

Albumin-stabilized polydopamine nanoparticles for chemo-photothermal synergistic therapy of melanoma

Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

Pharmacokinetics and Biodistribution of Surface Modification Polymeric Nanoparticles

Therapeutic Peptides Are Preferentially Solubilized in Specific Microenvironments within PEG-PLGA Polymer Nanoparticles

Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles